Rupert Walder provides a European perspective on reproductive health commodities (from contraceptives to testing kits to equipment for emergency obstetric care).
HIV/AIDS is about much more than the overwhelming numbers and the unfathomable ignorance that is promoted by ideologues. Some days it is about friends. Yesterday was one of those days.
Reproductive health for LGBT people is as diverse as our community and as varied as it is for heterosexual people. From creating family to accessing health care, reproductive justice is about the right to choose how we want to live our lives.
An HIV vaccine and microbicides both have huge potential to make a difference for reproductive health—especially for women of color, who are disproportionately affected by HIV/AIDS.
Two new technologies would improve women's options for protection from pregnancy and sexually transmitted infections: the PATH Woman's Condom and the SILCS diaphragm.
The "no period pill" Lybrel is more about marketing than new technology, yet it has met mixed reactions ranging from questioning women's very identity without menstruation to lauding a new option for preventing periods and pregnancy.
As women become more at risk for HIV, microbicides represent a promising technology that would allow women to initiate protection from sexually transmitted infections, as well as prevent pregnancy.
As Father's Day (June 17) marks the culmination of "Men's Health Week," Laura Lindberg talks about how we could do a better job of supporting young men's health.
Sex with multiple partners is gaining attention in sub-Saharan Africa in order to address a ballooning epidemic, where just 12 percent of men and 10 percent of women know their HIV status.
